HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Nephrotic syndrome and neoplasia: our experience and review of the literature.

Abstract
The glomerular lesion of paraneoplastic nephrotic syndrome usually presents as membranous nephropathy, minimal change disease or membranoproliferative glomerulonephritis. We present six cases of paraneoplastic nephrotic syndrome. Four cases were associated with epithelial malignancies (lung, gastric and colon cancer), and two cases with lymphoproliferative malignancies (Hodgkin's lymphoma and chronic lymphocytic leukemia). On the basis of light microscopy, immunofluorescence study and electron microscopy, membranous nephropathy, minimal change disease, and membranoproliferative glomerulopathy were established. We concluded, that the search for malignancy is warranted in patients over the age of 55 presenting with nephrotic syndrome, particularly in cases of membranous nephropathy.
AuthorsMałgorzata Wągrowska-Danilewicz, Marian Danilewicz
JournalPolish journal of pathology : official journal of the Polish Society of Pathologists (Pol J Pathol) Vol. 62 Issue 1 Pg. 12-8 ( 2011) ISSN: 1233-9687 [Print] Poland
PMID21574101 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Review)
Topics
  • Adenocarcinoma (epidemiology, pathology)
  • Aged
  • Comorbidity
  • Female
  • Hodgkin Disease (epidemiology, pathology)
  • Humans
  • Kidney Glomerulus (blood supply, ultrastructure)
  • Leukemia, Lymphocytic, Chronic, B-Cell (epidemiology, pathology)
  • Male
  • Middle Aged
  • Neoplasms (epidemiology, pathology)
  • Nephrotic Syndrome (epidemiology, pathology)
  • Paraneoplastic Syndromes (epidemiology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: